Literature DB >> 15279702

Regulation of cellular gene expression in endothelial cells by sin nombre and prospect hill viruses.

Svetlana F Khaiboullina1, Albert A Rizvanov, Elmer Otteson, Akira Miyazato, Jaroslaw Maciejewski, Stephen St Jeor.   

Abstract

Mechanisms of hantavirus-induced vascular leakage remain unknown. This study was initiated to determine whether hantavirus-induced changes in endothelial cell gene expression may provide insight into disease mechanisms. Additionally, by using pathogenic Sin Nombre virus (SNV) and non-pathogenic Prospect Hill virus (PHV), we wanted to identify cellular responses that are likely to differentiate pathogenic from nonpathogenic hantaviruses. Using the Affymetrix DNA Array, we found that PHV and SNV did not significantly differ in the number of activated genes (18 versus 14 genes) in infected endothelial cells at 4 h PI. However, a smaller group of genes (36) were up-regulated by PHV compared to SNV (175) at 12 h PI. Only two genes were down-regulated in SNV-infected cells. Expression of the functionally diverse group of genes was altered at an early stage of infection (4 and 12 h PI). The genes affected include putative anti-viral factors, transcription factors, growth factors, chemokines, receptors, structural proteins, metabolism, and kinases. Although many genes were activated in cells infected with SNV and PHV, overall cellular transcriptional responses were more altered by pathogenic SNV compared to non-pathogenic PHV. Copyright Mary Ann Liebert, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15279702     DOI: 10.1089/0882824041310504

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  13 in total

1.  Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling.

Authors:  Christina F Spiropoulou; César G Albariño; Thomas G Ksiazek; Pierre E Rollin
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

Review 2.  Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?

Authors:  Alison M Kell
Journal:  J Mol Biol       Date:  2021-09-04       Impact factor: 5.469

3.  HSP70 induced by Hantavirus infection interacts with viral nucleocapsid protein and its overexpression suppresses virus infection in Vero E6 cells.

Authors:  Lu Yu; Ling Ye; Rong Zhao; Yan Fang Liu; Shou Jing Yang
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

4.  Seoul virus enhances regulatory and reduces proinflammatory responses in male Norway rats.

Authors:  Judith D Easterbrook; Sabra L Klein
Journal:  J Med Virol       Date:  2008-07       Impact factor: 2.327

Review 5.  Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.

Authors:  Solène Lerolle; Natalia Freitas; François-Loïc Cosset; Vincent Legros
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

6.  Bunyaviruses and the type I interferon system.

Authors:  Richard M Elliott; Friedemann Weber
Journal:  Viruses       Date:  2009-11-23       Impact factor: 5.048

7.  Multiplex Analysis of Serum Cytokines in Humans with Hantavirus Pulmonary Syndrome.

Authors:  Sergey P Morzunov; Svetlana F Khaiboullina; Stephen St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Immunol       Date:  2015-08-31       Impact factor: 7.561

8.  Elevated VEGF Levels in Pulmonary Edema Fluid and PBMCs from Patients with Acute Hantavirus Pulmonary Syndrome.

Authors:  Irina Gavrilovskaya; Elena Gorbunova; Frederick Koster; Erich Mackow
Journal:  Adv Virol       Date:  2012-08-22

Review 9.  Immunological mechanisms mediating hantavirus persistence in rodent reservoirs.

Authors:  Judith D Easterbrook; Sabra L Klein
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

Review 10.  What Do We Know about How Hantaviruses Interact with Their Different Hosts?

Authors:  Myriam Ermonval; Florence Baychelier; Noël Tordo
Journal:  Viruses       Date:  2016-08-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.